Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options
Prior studies have shown that SIGLEC1 interacts with CD43 in CD4 T cells, thereby suppressing pro-inflammatory cytokine production 74
D., Dolan, C
The VEGFR2-independent mechanism involves Src kinase-mediated phosphorylation of caveolin-1, disrupting the inhibitory interaction between caveolin-1 and eNOS
US$ 26.02
US$ 26.42
US$ 26.05
US$ 20.35
US$ 26.65
US$ 25.70
